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Abstract
Identifying protein post-translational modifications (PTMs) from tandem mass spectrometry data
of complex proteome mixtures is a highly challenging task. Here we present a new strategy,
named iterative search for identifying PTMs (ISPTM), for tackling this challenge. The ISPTM
approach consists of a basic search with no variable modification, followed by iterative searches
of many PTMs using a small number of them (usually two) in each search. The performance of the
ISPTM approach was evaluated on mixtures of 70 synthetic peptides with known modifications,
on an 18-protein standard mixture with unknown modifications and on real, complex biological
samples of mouse nuclear matrix proteins with unknown modifications. ISPTM revealed that
many chemical PTMs were introduced by urea and iodoacetamide during sample preparation and
many biological PTMs, including dimethylation of arginine and lysine, were significantly
activated by Adriamycin treatment in NM associated proteins. ISPTM increased the MS/MS
spectral identification rate substantially, displayed significantly better sensitivity for systematic
PTM identification than the conventional all-in-one search approach and offered PTM
identification results that were complementary to InsPecT and MODa, both of which are
established PTM identification algorithms. In summary, ISPTM is a new and powerful tool for
unbiased identification of many different PTMs with high confidence from complex proteome
mixtures.
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INTRODUCTION
Post-translational modifications (PTMs) of proteins play an extensive and pivotal role in
eukaryotic signal transduction, gene regulation, and metabolic control in cells.1, 2 PTMs
determine protein conformation, activity, and localization, as well as stability.1 Abnormal
PTMs are often a cause or consequence of many pathological and disease conditions.3
Although they are important, system-wide identification of PTMs remains a highly
challenging task for many reasons. First, PTMs display enormous diversity and complexity.4
There are more than 300 PTMs that are known to occur physiologically. Vertebrate proteins
often undergo multiple PTMs at the same time. It was estimated that for human proteins
there are 8~12 modified versions for each unmodified tryptic peptide.5 Second, PTMs
generate complex fragmentation patterns in tandem mass spectrometry. This complexity
poses a significant challenge for subsequent data analysis. Third, PTMs are usually present
at low stoichiometry and low-abundance. Fourth, global proteomic studies are often limited
to a specific PTM due to the prerequisite of effective enrichment strategies that employ
specific PTMs.2 An unbiased approach for system-wide identification of many different
PTMs in complex proteome mixtures is highly desirable.
Currently, liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is
the central method for identifying proteins with PTMs.1, 6 A particular advantage of this
technique is that the MS/MS spectra contain information both on the intact full length
peptide and on the masses of fragment ions from which amino acid sequences with specific
sites of PTM can be derived. Typically, a modified peptide is identified through a process of
peptide-spectrum-match (PSM) using programs such as SEQUEST7, Mascot8, or OMSSA9
to compare the observed spectral data to a protein database. Identification by these
algorithms is based on a restricted database search in which MS/MS spectra are aligned with
protein sequences bearing a few specified PTMs attached to specific amino acids. These
approaches are not very effective at identifying large numbers of PTMs from complex
proteome mixtures because the database search space expands exponentially as the number
of PTMs increases. This increases the search time and false positive rate. For these reasons,
it is generally advisable to include a limited number of variable modifications during
database searches using conventional database search engines such as SEQUEST and
Mascot.
To overcome the drawbacks of conventional database search methods, a number of
strategies for unrestricted PTM identification have been developed, such as the de novo
sequencing approach, sequence-tag approach, and spectral matching approach.10 Each
approach has its own strengths and weaknesses. For example, the blind search methods,
such as InsPecT11, can identify all possible PTMs at once, especially the unknown and
unexpected PTMs. However, it is sensitive to the size of protein database, and a double pass
strategy is recommended to increase the specificity when the database is over ten million
amino acids.12 The double pass strategy identifies proteins in the sample using unmodified
peptides (or minimally modified peptides) in a first pass, and then reduces the database to
include only those identified proteins and search it for a wide selection of modified peptides
in a second pass. Recently, Na et al developed a novel blind search tool named MODa,
which can perform fast and unrestrictive searches for large scale databases of the human
proteome.13 Using a dynamic programming method, MODa solved the limitation of the
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number of unrestrictive PTMs that can be allowed in each peptide. However, MODa was not
designed to address the accurate localization of modifications to specific sites in the
identified peptide sequences.13 Other approaches, such as ModifiComb and DeltAMT, can
identify both known and unknown PTMs from complex mixtures in a quick fashion.10,14
However, because these spectrum match algorithms are based on the similarity of mass
shifts and retention times between the unmodified form and its modified counterpart, they
are insensitive to the quality of MS/MS spectra. Thus they may not accurately localize the
modification site for a PTM that may occur on different amino acid residues in the same
peptide.
Here we report a novel strategy, named ISPTM (iterative search for peptide identification
with PTMs), for the systematic identification of PTMs with site-specific confidence from
complex MS data. The iterative search strategy concept has been applied to some
conventional search engines (such as X!Tandem, Mascot and SEQUEST) by early
developers, but with the double pass strategy.14, 15 However, our ISPTM approach differs
from these iterative search approaches by refining the MS/MS spectra instead of refining the
database. ISPTM enables the identification of PTMs from complex peptide mixtures without
prior identification of the proteins in the sample. The performance of ISPTM was evaluated
using three datasets with different levels of protein complexity. Our results indicated that the
ISPTM approach substantially increased the MS/MS spectral identification rate,
demonstrated significantly better sensitivity for global PTM identification than the
conventional all-in-one search approach, and provided PTM identification results
complementary to those from InsPecT and MODa. Using ISPTM, we found that many
biologically meaningful PTMs, as well as some chemical modifications, occurred on the
nuclear matrix (NM) proteins of mouse pro-B 2A cells after ADR-induced DNA damage.
MATERIALS AND METHODS
Preparation and LC-MS/MS analysis of the synthetic peptide samples
Two synthetic modified peptide mixtures were received from the Proteomics Standards
Research Group at the Association of Biomolecular Resource Facilities. One (sample#1)
contained a lyophilized mixture of 70 synthetic modified peptides, and the other (sample#2)
contained the same mixture combined with a tryptic digest of six proteins from which the
synthetic peptides were derived. More details of these samples are available at
www.abrf.org/sprg, survey project 2011. Peptide samples were analyzed using an Easy
nanoLC, equipped with a 75 Vm × 10 cm, Magic C18 AQ LC column, coupled to a Q-
Exactive mass spectrometer (Thermo Scientific, San Jose, CA) as previously described.16
18-protein Standard mixture data
Datasets for an 18-protein standard mixture were downloaded from the Institute for Systems
Biology (ISB) website.17 These datasets were analyzed by InsPecT and MODa. Briefly, the
mgf files were searched against the ISB database of 18 standard proteins plus 92
contaminant proteins and 1709 Haemophilus influenzae RD proteins as background
(obtained from ISB website). Carbamidomethylation of cysteine was used as the fixed
modification. Only one modification was allowed in each peptide. In InsPecT, all the
identified spectra were collected by applying a filter of p-value less than 0.05. An FDR
cutoff of 0.01 was applied for the filtered spectra based on the F-score. In MODa, a
probability score > 0.95 was applied, and an FDR cutoff of 0.01 was used to filter the
spectra by the PSM score. In ISPTM, the OMSSA outputs were collected and filtered by p-
value < 0.05, and an FDR cutoff was applied based on the OMSSA E-value.
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Preparation and LC-MS/MS analysis of the NM samples
Abelson virus-transformed mouse pro-B cell line 2A was maintained in RPMI media
supplemented with 10% fetal bovine serum and 12.5 VM β-mercaptoethanol (Invitrogen,
Carlsbad, CA). Pro-B 2A cells were treated with either 1 μM Adriamycin (Sigma-Aldrich,
St Louis, MO, dissolved in DMSO) or DMSO alone for 4 hours. All buffers for NM sample
preparation contained 1% protein phosphatase inhibitor cocktail 1, 1% protein phosphatase
inhibitor cocktail 2, 1% protease inhibitor cocktail, and 1.2 nM phenyl methane sulfonyl
fluoride (all from Sigma). Cell lysates were re-suspended in CSK buffer (10 mM PIPES pH
6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% Triton X-100, 1
mM dithiothreitol (DTT), all from Sigma) and incubated on ice for 5 min. After
centrifugation at 9000 rpm for 1 min, the pellet was re-suspended in low salt extraction
buffer (42.5 mM Tris HCl pH 8.3, 8.5 mM NaCl, 2.6 mM MgCl2, 1% Tween 40, 0.5%
deoxycholic acid) and incubated on ice for 5 minutes, followed by centrifugation at 9,000
rpm for 1 min. Again, the pellet was re-suspended in digestion buffer (10 mM PIPES pH
6.8, 50 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1mM EGTA, DNase (500 u/mL, Roche,
Indianapolis, IN), RNase (500 u/mL, Ambion, Austin, TX), 0.5% Triton X-100, and 1 mM
DTT) and incubated at room temperature for 1 hour with gentle shaking. The concentration
of ammonium sulfate was adjusted to 0.25 M and the preparation was incubated for a 10 min
extraction period, at room temperature. By centrifugation at 13,000 rpm for 1 min, the pellet
was washed with 2 M NaCl buffer (2 M NaCl, 10 mM PIPES, pH 6.8, 10 mM EDTA). After
a final centrifugation at 13,000 rpm for 1 min, the pellet was re-suspended in lysis buffer (8
M urea, 50 mM ammonium bicarbonate) and incubated at 37°C overnight to dissolve the
nuclear matrix-associated proteins. All centrifugations were performed at 4°C.
Methods for sample preparation, trypsin digestion, strong cation exchange (SCX)
chromatography, and LC-MS/MS analysis of the NM protein digests were described
previously.18 Briefly, two NM protein samples were reduced with DTT and
carboxyamidomethylated with iodoacetamide (IAA) at room temperature. Tryptic digestion
was performed and the resulting peptides were desalted by solid phase extraction. SCX
separation was performed and twenty fractions were obtained from each NM sample. These
fractions were analyzed by LC-MS/MS on a nanoLC coupled with LTQ-Orbitrap-XL mass
spectrometer (Thermo Scientific).
Database and computing resources
For the synthetic peptide data, we used a protein database containing the six proteins that the
modified peptides belong to, plus four contaminate proteins, 1,990 background proteins
from both the human and bovine proteomes, and the reverse sequences for all of these 2,000
proteins (obtained from the sPRG 2011 survey project). For the ISB data, the same database
was used. For the NM data, MS/MS spectra were searched against i) a concatenated
database containing 55,303 proteins from the international protein index (IPI) mouse
database (version 3.52), ii) the commonly observed 262 contaminants (forward database),
and iii) the reversed sequences of all 55,565 proteins from i and ii (reverse database). The
OMSSA engine (v2.1.9, Linux version) was used for the database searches. The initial mass
deviation tolerance of precursor ion was set to 0.02 Da and fragment ion tolerance was set to
0.5 Da for the NM data. The initial mass deviation tolerance was 0.02 Da and the fragment
ion tolerance was 0.05 Da for the synthetic peptide mixture data. A maximum of 2 missed
cleavages were allowed in peptide identification. We also employed a multi-blind search
with the MODa software to analyze the NM data, using the same settings of ISPTM. Both
ISPTM and MODa searches were performed using the computing resources available at the
University of Nebraska Holland Computing Center (HCC).
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ISPTM analysis of the data
The ISPTM approach consists of four steps. Step 1: the MS/MS raw data were pre-processed
by DeconMSn and DtaRefinery as previously described.18 MS/MS spectral data were then
stored in mgf format ready for the OMSSA search. Step 2: a basic search was performed
with carboxyamidomethylation of cysteine as a fixed modification (no variable
modifications in this step). The identified unmodified peptides were filtered by OMSSA E-
value cutoff of < 0.01. Step 3: the identified MS/MS spectra from Step 2 were removed from
the initial spectrum pool, and the remaining spectra were used for iterative searches. In this
step, each cycle tested a small number of variable modifications (1, 2 or 3) until all
combinations of the modifications were tested. For the synthetic peptides data, ISPTM
searches were made in five variations: 1) testing 13 known modifications taken two-at-time
(IS-13, 13×12/2 = 78 runs), 2) testing these 13 authentic modifications plus 13 false
modifications (Supplemental Table 1) taken two-at-time (IS-26, 26×25/2 = 325 runs), 3)
testing all (207) modifications in the OMSSA database, one-at-time (IS-Single, 207 runs), 4)
testing all OMSSA modifications two-at-time (IS-Double, 207×206/2 = 21,321 runs), and 5)
testing all OMSSA modifications three-at-time (IS-Triple, 207×206×205/(3×2) = 1,456,935
runs). For the ISB data, iterative searches were performed by the IS-single strategy, testing
207 modifications one-at-time. For the NM data, we removed 46 modifications (chemical
modifications using stable isotope labels, Supplemental Table 2) that cannot occur in our
biological samples, and iteratively searched the rest of the modifications using the IS-double
strategy. The modified peptides that were identified were filtered by OMSSA E-value cutoff
of < 0.1. In the case of multiple peptide sequences identified from the same MS/MS
spectrum, the peptide sequence with the smallest E-value was retained. Step 4: all
identification results were combined and exported with a fixed FDR, followed by calculation
of site confidence score for each modification site.
Site confidence score for identification of peptides with PTMs
To provide an empirical measure of confidence that a PTM site was correctly localized a
probability-based significance was calculated using the site-determining product ions.
Briefly, a probability distribution P(X) is based on the hypothesis that random sampling of
fragment ions in an MS/MS spectrum follows a binomial distribution:
(Eq. 1)
where p is the probability of matching a fragment ion in a sampling event, and N and k
represent the theoretical and observed site-determining fragment ions from the MS/MS
spectrum.
For each modified peptide, the site confidence (SC) score for a PTM at position i is
calculated as:
(Eq. 2)
where Pj is the false positive (FP) probability that a PTM is located at position i but not at
position j in the same peptide.
To calculate the SC score, the MS/MS spectra were preprocessed to create a list of observed
fragment ions that contained the 6 most intense fragment ions per 100 m/z units. Masses of
theoretical ions for each identified peptide were obtained from MS-Product (http://
prospector.ucsf.edu/prospector/). For each identified peptide with a PTM at position i, the
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alternative forms of modifications include: 1) the same PTM at other possible sites, 2) a
different PTM with similar mass shift (<0.02 Da, identical to the OMSSA tolerance of
precursor ions) in this peptide. For each alternative PTM at position j, N (total number of
site-determining ions), k (number of observed fragment ions that matched the theoretical ion
using a mass tolerance of 0.5 Da) and p (=0.06) were used to calculate the Pj. Then the SC
score was determined by 1 minus the sum of Pj of all alternative forms.
RESULTS
Overview of the ISPTM approach
The ISPTM work flow is summarized in Figure 1. Scripts written in Python were used to
perform tasks including spectra refining, filtering the spectra of unmodified peptides, setting
the pool of PTMs and the number of variable modifications in each iterative search,
generating the commands for OMSSA searches, collecting and filtering the identification
results, and annotating the site confidence of PTMs. The python scripts are fully automatic
in each step, minimizing the user’s intervention. The outputs of ISPTM follows the same
format of standard OMSSA csv outputs, with a new column indicating the SC score for each
PTM site. The Python scripts and instructions have been deposit on Google Code (https://
code.google.com/p/isptm-python/). The ISPTM analyses of the synthetic peptides and the
NM data were both finished in less than 48 hrs.
ISPTM Analysis of the Synthetic Modified Peptide Mixtures with Known Modifications
In the synthetic modified peptide mixtures, peptide “NGDTASPKEYTAGR” with 3
different methylated forms of lysine (methylation, dimethylation and trimethylation) were
identified in a single conventional search allowing all 13 modifications as variable
modifications. In ISPTM, an iterative database search was applied and matches were found
when the mono-, di- and tri-methyl modifications were tested, respectively (Supplemental
Figure 1). We evaluated the performance of ISPTM using the synthetic modified peptide
mixtures and compared it to the conventional all-in-one search. In total, 41 peptides were
identified from 278 spectra by the conventional search of sample #1, while 45 peptides were
identified from 358 spectra by the ISPTM method using the 13 modifications taken two-at-
time (IS-13). Using a false discovery rate (FDR) < 0.1, only 13 peptides (out of 109 spectra)
from the conventional search were acceptable, while 32 peptides (out of 239 spectra) were
acceptable from the ISPTM method. A detailed comparison of conventional and ISPTM
search results with different strategies for analysis of the synthetic peptide data is displayed
in Supplemental Table 3.
The overall performance of the conventional search and ISPTM approaches with multiple
strategies for sample#1 was compared using the receiver operating characteristic (ROC) plot
(Figure 2A). The ROC plot demonstrated that an iterative search using the IS-13 strategy
achieved the best discriminating power between the authentic and false positive
identifications. The discriminating power was essentially the same if another 13 false
modifications were included in the ISPTM search (IS-26). We further tested the
performance of ISPTM on the synthetic peptides by using the 207 modifications in the
OMSSA modifications pool in the search. In these analyses, variable modifications were
used one-at-time (IS-Single), two-at-time (IS-Double) or three-at-time (IS-Triple). ROC
analysis indicated that IS-13 and IS-26 strategies had higher discriminating power than the
IS-Single, IS-Double, and IS-Triple strategies. Interestingly, performances of all these
ISPTM strategies were essentially the same if ROC analysis was applied to identification
results from sample #2 (Figure 2B). Overall, all the iterative searches showed superior
discriminating power compared to the conventional all-in-one approach. The discriminating
power of the IS-Single, IS-Double, and IS-Triple strategies increase for sample #2,
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compared to sample #1, mainly because the peptides in sample #2 are more complex than in
sample #1 and many natural modifications, such as oxidation of methionine and acetylation
of the protein N-terminus are present.
We also noticed that the PSM score may change when different numbers of variable
modifications were used. As shown in Figure 2C, for the same spectra with same
identification results, the PSM score [represented by the −log10(E-value)] was plotted for the
conventional and the IS-Double search results. The regression line with a slope ≈ 1 and an
intercept of 1.29 indicates that the PSM score for the IS-Double search is slightly higher
than the PSM score for the all-in-one search. This is the reason why the discriminating
power decreased in the conventional all-in-one search. However, there is almost no
difference in the PSM score when the IS-Double and IS-Triple search results were compared
(slope = 1, intercept ≈ 0, Figure 2D).
Analysis of ISB data
We employed InsPecT, MODa, and our ISPTM approach to analyze the ISB data. By FDR
< 0.01, InsPecT, MODa and ISPTM identified a total of 5,790, 11,233 and 9,556 spectra,
respectively. Among these spectra, 1,639, 3,012 and 2442 were identified as modified
peptides by InsPecT, MODa and ISPTM, respectively. All peptide/protein identifications are
listed in Supplemental Table 4, with a PTM frequency matrix11 was developed for the
modified spectra for each program. A Venn gram shows the different coverage of identified
peptides, as well as the modified peptides (peptides with identical sequence, modification
site, and mass shift) by these approaches (Figure 3A and 3B). Overall, InsPect, MODa and
ISPTM provide complementary identification coverage for the ISB dataset. MODa
identified more peptides than InsPect and ISPTM. As shown in Table 1, the most frequent
modifications identified by both InsPecT and MODa results were the sodium and potassium
adducts. Other frequent PTMs identified by both programs include oxidation of methionine,
carbamidomethylation of cysteine, and several biologically relevant PTMs, such as
dehydration by beta-elimination of serine and threonine, and peptide N-terminal acetylation.
In the ISPTM analysis, the most frequent modification was deamidation of asparagine.
Consistent with the InsPecT and MODa results, oxidation of methionine, acetylation of the
protein N-terminal, and beta-elimination of serine and threonine were identified.
Interestingly, ISPTM also identified many peptides with cyclization of the N-terminal S-
carbamidomethyl cysteine (Pyro-CamC) and N-terminal pyro-glutamic acid (Pyro-Glu).
ISPTM Analysis of the Global PTMs in Nuclear Matrix Samples
We evaluated the ISPTM approach using a pair of complex biological samples: nuclear
matrix protein digests of mouse Pro-B cells before (Control) and after DNA damage (ADR-
treated). Using the basic search for unmodified peptides, with E-value < 0.01, 9,315 and
5,527 MS/MS spectra were identified from the Control and ADR-treated samples,
respectively. The number of false positive peptides, identified at the spectrum level, from
the Control and ADR-treated datasets were 8 and 51 (both FDR < 0.01), respectively. Using
the ISPTM approach with two variable modifications at a time, 28,595 modified peptide
spectra were identified by Evalue < 0.1. By applying the FDR cutoff of 0.01, we identified
1,921 unique peptide sequences from 5,068 MS/MS spectra, of which 1,700 spectra were
from the Control samples and 3,368 spectra were from ADR-treated samples. In the ISPTM
results, 32.5% (625/1921) of the modified peptides were identified with an unmodified form
in the basic search. At the protein level, 62.1% (907/1460) of the modified proteins were
identified in the basic search. MODa was used to analyze the NM data as well. By FDR <
0.01, MODa identified 5,492 and 3,102 spectra of unmodified peptides as well as 1,857 and
4,437 spectra of modified peptides from the Control and ADR-treated samples, respectively.
For the combined Control and ADR-treated nuclear matrix samples, ISPTM identified more
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unique peptides and proteins than MODa (Figure 3C and 3D). However, MODa identified
more modified peptides with either identical sequences or identical modifications than
ISPTM (Figure 3E and 3F).
The frequencies of identification for modified peptides obtained by the ISPTM approach
were shown in Supplemental Table 5. First, we applied an SC cutoff of 0.8 to remove the
unconfident modifications. Then manual curation was performed for the results. For
example, we found that OMSSA assigned ubiquitination, methylation and sumoylation to
lysines and arginines at the C-terminus of some peptides. But a modified lysine or arginine
is generally not recognized by trypsin for digestion and therefore could not appear at the C-
terminus of a tryptic peptide. We also identified some spectra with O-GlcNAcylation to
serine and threonine. Because O-GlcNAc is readily lost as an oxonium ion during collision-
induced dissociation,19 it renders the identification of O-GlcNAc modified peptides very
difficult. Thus such assignments were removed from the identification results. As a result,
we obtained 4,166 spectra identified for a total of 1,636 unique peptides (an entire list of
identified peptides with PTMs is presented in Supplemental Table 6). The three most
frequent modifications were carbamylation of lysine, carbamylation of the peptide N-
terminal, and acetylation of protein N-terminal. For example, a peptide with carbamylation
at lysine was shown in Supplemental Figure 2A. This modification is induced presumably
by urea in the sample lysis buffer.20 Another reagent commonly used during proteomics
sample preparation is iodoacetamide (IAA). It is used to alkylate cysteines exposed by
reduction of disulfide bonds. We found that histidine, glutamic acid, aspartic acid, and lysine
were also alkylated by IAA.21 A peptide with carboxyamidomethylation at histidine was
shown in Supplemental Figure 2B. Pyro-Glu modification appears in 128 spectra
(Supplemental Figure 2C), because N-terminal glutamine or glutamic acid residues are
known to form Pyro-glu under aqueous conditions.22 Another frequent chemical
modification was Pyro-CamC at N-terminal cysteines, as shown in Supplemental Figure 2D.
This modification has been reported to be caused by enzymatic digestion of proteins that
have been S-alkylated by IAA.23
Deamidation of asparagine and glutamine was identified in 247 and 34 spectra in the NM
samples (Supplemental Figures 3A and 3B). It has been reported that deamidation is
involved in the “DNA damage-induced cellular response”.24 Moreover, this modification
can be caused chemically, especially during sample storage at higher temperature or when
the asparagine or glutamine is followed by glycine.25 Two additional PTMs, oxidation of
methionine and acetylation of the protein N-terminal, which are often included in routine
database searches, were identified in 183 and 249 spectra, respectively (Supplemental
Figures 3C and 3D). ISPTM results indicated that the chemical modifications are quite
abundant in the proteomics samples. It is important that they are included in routine database
searches because their presence may affect the identification of other modifications. For
instance, Figure 4A shows an annotated MS/MS spectrum of peptide “GVLKVFLENVIR”
derived from histone H4 position 57~68. Previous studies have reported that the lysine
residue at position 60 (H4K60) can be acetylated26, ubiquitinylated27, or formylated28
physiologically. In our study, all three forms of modification on H4K60 were identified, but
all peptides were also carbamylated on the N-terminal glycine (Figure 4B – 4D). Using the
conventional database search approach, these spectra would not likely have been identified
because carbamylation of the N-terminal glycine is not a common modification and
therefore is not normally included as a variable modification.
The numbers of identified unique peptides corresponding to selected PTMs from the Control
and ADR-treated NM samples are compared (Figure 5A). The number of peptides with
deamidation of asparagine, which is the most frequent PTM, is similar in the two samples.
The number of peptides with oxidized methionine decreased about 50% after ADR
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treatment. Oxidative stress may cause oxidation of methionine in vivo.29 However, this
modification may also occur in vitro during the sample preparation. The number of peptides
with dimethylated arginine increased in the ADR-treated sample. It has been reported that
dimethylation of ribonucleoproteins (RNP) increases their ability to bind DNA and to
promote gene transcription.30 Table 2 lists a number of peptides that were found to carry
dimethylated arginine, and their corresponding proteins. Dimethylated arginine has been
reported previously for some of these proteins: Hnrnpa0, Hnrnpa1, Pabpc1, Ewsr1, Snrpb,
Hnrnph1, and Hnrnpu.30 A representative peptide with dimethylated arginine at Hnrnpa0 is
shown in Supplemental Figure 4A. Neutral-loss of a monomethylamine (H2N-CH3) group
indicated that this is a symmetric dimethylation site.31 Other RNP proteins (Hnrnpa1) and
Pabpc1 (Supplemental Figure 4B) were identified with dimethylation, indicating that this
modification is essential for normal mRNA metabolism. Interestingly, dimethylation of
arginine at Ewsr1 (Supplemental Figure 4C), Snrbp, Rbm33 (Supplemental Figure 4D),
Hnrnph1, and Hnrnpu were only observed after ADR treatment. The function of
dimethylation on these proteins remains unknown.
A glycyl (GG) modification on lysine is a degradation signal for ubiquitination.32 Figure 5B
shows the annotated MS/MS spectrum of “LIFAGKQLEDGR”, which is a signature tryptic
peptide of the protein with K48 poly-ubiquitination.33 Interestingly, the ubiquitination
modification site on histone H4 (H4K60) was found to be the site of formylation after ADR
treatment. As a secondary modification that results from oxidative DNA damage,
formylation of lysine in histone proteins may interfere with the signaling functions and thus
contribute to the pathophysiology of oxidative and nitrosative stress.34 All the above data
indicate that PTMs on many NM proteins, especially the core histones, were altered by
treatment with ADR. Such modifications may change the activity and function of these
proteins in response to ADR-induced DNA damage.
DISCUSSION
PTMs are extremely important for maintaining protein structure and function. We present in
this paper a novel strategy named ISPTM to identify the proteins with complex patterns of
PTMs from LC-MS/MS data. Compared to the conventional all-in-one search strategy,
ISPTM can effectively control the search space by including a very limited number of PTMs
in a search and has higher discriminating power for the true PTMs as we demonstrated in
Figure 2A and 2B. In contrast, when a large number of PTMs needed to be tested in a
sample, it will be increasingly difficult to use the conventional all-in-one search because of
the exponential increase of search space and reduced PSM score to discriminate the true
PTM identifications from the false identifications (Figure 2C). The unique feature of the
ISPTM approach is that it performs an exhaustive search for hundreds of different
modifications expected to be found in complex protein samples, including both naturally
occurring and chemical modifications. Our data indicated that a large portion of peptides are
chemically modified by carboxyamidomethylation, carbamylation and deamidation, but
these chemical modifications are generally not considered in routine database searches.
Importantly, our approach has demonstrated that identifying peptides with various (either
chemical or biological) modifications in a sample can not only increase the spectral
identification rate but also can increase the chance of identifying key protein regulators and
their possible PTMs.
One limitation of ISPTM is that it is not designed to discover totally unknown
modifications. All modified peptides are identified from a pre-defined pool of modifications.
Nevertheless, the current UNIMOD database (www.unimod.org) contains more than a
thousand modifications.35 This pool could be employed in place of the OMMSA pool,
which currently contains 207 modifications. However, instead of testing all PTMs in this
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pool (i.e. Mascot error tolerant search), users can choose a small subset of interested PTMs
to perform ISPTM. For a relatively simple mixture like the ISB data, we demonstrated that
the performance of the ISPTM approach is equivalent to the blind searches engines InsPecT
and MODa, when all possible modifications were tested.
When analyzing more complex proteome mixtures like the NM dataset here, ISPTM
identified about 72% more spectra (14842/8594) of unmodified peptides, whereas it
identified about 19% less (5068/6294) spectra of modified spectra, compared to the outputs
of MODa. Here we interpret these results in several aspects: First, a restrictive engine such
as OMSSA is better than unrestrictive engines in identifying unmodified peptides. Second,
ISPTM separates the modified and unmodified peptides and applies FDR individually. By
an FDR of 0.01 in the NM data, E-value cutoff of unmodified peptides was 0.01, while
cutoff of modified peptides was 2.8E-6. This might be another reason that ISPTM identified
fewer modified peptides than MODa. Third, both results contain false positive
identifications even though an FDR cutoff has been applied. However, a fixed modification
at a specific site in restrictive searches can minimize the artifacts. For instance,
carbamylation (+43) only occurs at a peptide N-terminal and lysine, but we also observed a
number of spectra were identified within other sites in MODa. Another advantage of the
ISPTM approach over blind search or de novo methods is that the identification results are
very easy to interpret, because all modifications are known and with clear site specificity.
Finally, the large number of potential modifications provides the both algorithms with wide
latitude for making assignments. Consequently, even peptides with strong scores can prove
to be assigned incorrectly. Thus we strongly suggest that modification results be confirmed
by manual sequencing and orthogonal approaches such as site-directed mutagenesis or MS/
MS analysis of the synthetic peptide with a specific modification.36
In this paper we introduced an SC score method to access the site confidence of the
identification results. Although both the SC score and a former A-score37 methods are based
on a cumulative binomial distribution model (measuring the likelihood of matching at least
the number of matched site-determining ions by chance), we think that the SC score
developed in this manuscript may have several advantages. First, A-score is an ambiguous
score that only distinguishes the top two candidate sites, but SC score considers all possible
candidate sites. Second, A-score is restricted on the same modification at different sites (i.e.,
phosphorylation on S/T/Y). However, if many PTMs with identical or close mass shifts are
involved in a search like in the case of ISPTM search, it is difficult to determine exactly
which PTMs are occurring and distinguish them. For instance, deamidation and
citrullination have exactly the same mass-shift. And the mass-shift between acetylation and
tri-methylation is very close, differing only by 0.036 Da. Such a small difference is
undetectable in low-resolution MS but detectable in high-resolution MS. Our scripts
calculate the mass shifts of all possible PTMs included in the search and the mass tolerance
of all identified peptides automatically, providing the SC score without user intervention.
Third, because the SC score is a confidence score, users can apply a certain cutoff (i.e., 0.8)
to filter out the ambiguous PTM identification results. To summarize, the SC score
developed here allows for more PTM assignments in a high throughput fashion. However, in
the current design of ISPTM, it does not allow for assignment of novel PTMs unless this
novel PTM is included in the ISPTM search.
The OMSSA search engine was chosen for testing our ISPTM approach in the current study
because it is open-source and platform-independent.9 However, in principle, ISPTM can be
applied to other search engines, such as SEQUEST and Mascot. The computational resource
required is an important concern for large scale PTM identification of complex proteome
data. In this study, the cumulative CPU hours for analyzing the NM datasets by ISPTM was
4,535 hours, while the cumulative CPU hours for analyzing the NM datasets by MODa was
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834 hours (Supplemental Table 7). Dependent on the number of cores/CPUs available for
parallel computing, an ISPTM search of complex proteome datasets could be completed in a
few hours. In this study, we used a 1,151 node Linux cluster for our analyses because we
were analyzing up to 207 modifications. Such a large computing resource currently may not
be available to all investigators. However, most studies would be expected to involve a
smaller set of PTMs (less than 20). We have shown that the ISPTM approach has superior
performance in testing 13 modifications compared to the all-in-one search. For those studies,
a desktop PC would be suitable for iteratively testing one or two modifications at a time.
Moreover, the issue of computing power should be addressed by the rapid development of
modern computational technology such as supercomputers and cloud computing.38 Indeed,
any academic researcher in the United States already has access to a large computational
resource via OSG (Open Science Grid, https://www.opensciencegrid.org) or, more broadly,
XSEDE (Extreme Science and Engineering Discovery Enviroment, https://www.xsede.org/).
CONCLUSIONS
In summary, we have developed a novel approach, termed ISPTM, for the systematic
identification of PTMs in proteome samples. The ISPTM approach enables conventional
database search methods to be used for systematic PTM identification. The results obtained
with ISPTM demonstrated that chemical modifications such as carboxyamidomethylation of
histidine, glutamic acid, aspartic acid, and lysine and carbamylation of lysine are abundant
when IAA and urea are used in sample preparation. With the increasing size of the PTM
knowledge database, the ISPTM approach will bring the level of PTM identification from
the era of limited identification and quantitation to the level of global PTM discovery for
complex biological samples.
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Work flow of the ISPTM approach. Four steps are involved: 1) MS/MS spectra refining, 2)
basic search, 3) iterative searches, and 4) data collection, filtering, and output. All steps are
automated by Python scripts. The OMSSA search engine is used for all database searches.
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Comparison of the synthetic peptides data identified by conventional search and ISPTM.
(A–B) Receiver operating characteristic (ROC) plots illustrate the discriminating power of
different search strategies for (A) sample #1 and (B) sample #2. Search strategies include the
conventional (Conv.) all-in-one search using 13 variable modifications, and variations on
ISPTM strategy: iteratively testing 13 authentic modifications used two-at-time (IS-13),
testing 13 authentic modifications plus 13 false modifications used two-at-time (IS-26),
testing all 207 modifications provided by OMSSA used one-at-time (IS-Single), testing all
207 modifications provided by OMSSA used two-at-time (IS-Double), and testing all 207
modifications provided by OMSSA used three-at-time (IS-Triple). (C–D) OMSSA E-value
comparison of the same identification results using different search strategies. For the same
spectrum with same OMSSA identification results in Sample #1, the PSM score by
−log10(E-value) from (C) the conventional all-in-one search and IS-Double search
strategies, and (D) from the IS-Double and IS-Triple search strategies were plotted. Linear
regression was applied for each plot and the regression equation and R2 are indicated in each
plot.
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Comparison of the ISB data analyzed by ISPTM, MODa and InsPecT approaches, as well as
the complex nuclear matrix data analyzed by ISPTM and MODa. (A–B) Different coverages
of the (A) unique peptides (peptides with identical AA sequence but different modifications)
and the (B) modified peptides (peptides with identical AA sequence and identical
modification) identified by three programs for the ISB data. (C–F) Different coverages of
the (C) unique proteins, the (D) unique peptides, the (E) unique modified peptides (modified
peptides with identical AA sequence but different modifications), and the (F) modified
peptides (modified peptides with identical AA sequence and identical modification) by
ISPTM and MODa for the nuclear matrix data.
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The MS/MS spectra of peptide “GVLKVFLENVIR” derived from Histone H4
(IPI00407339) with a variety of PTMs on lysine 60 (H4K60): (A) Unmodified peptide, (B)
formylated lysine, (C) acetylated lysine, and (D) ubiquitinylated lysine. All of these peptides
were carbamylated on the N-terminus. Mass and charge of the precursor, OMSSA E-value,
and the modification site confidence score are indicated in each MS/MS spectrum.
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Changes in PTM on the nuclear matrix proteins from mouse pro-B cells after DNA damage,
analyzed by ISPTM. (A) A bar graph showing the number of unique peptides found for a
representative set of PTMs that were identified in the Control (Ctrl) and ADR treated
samples. (B) The MS/MS spectrum of peptide “LIFAGK(GG)QLEDGR” which was derived
from a protein with K48 poly-ubiquitination, that appeared after DNA damage. Mass and
charge of the precursor, OMSSA E-value, and the modification site confidence score are
indicated in each MS/MS spectrum.
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Table 1
The frequent modifications of ISB data analyzed by InsPecT, MODa, and ISPTM.
Residues Mass Shift Spectra Annotations
Modifications by InsPecT:
 Nonspecific 22 294 Sodium
 Nonspecific 38 151 Potassium
 M 16 92 Oxidation
 C 209 85 Carbamidomethylation by DTT
 N or protein N-terminus −17 83 Amonia loss
 Protein N-terminus 42 44 Acetylation
 S 42 44 Acetylation
 M 15 31 Unknown
 A 26 29 A->P substitution
 N-terminus 128 25 Unknown
Modifications by MODa:
 Nonspecific 22 558 Sodium
 N 1 514 Deamidation
 Nonspecific 38 279 Potassium
 M 16 273 Oxidation
 C 152 163 Carbamidomethylation
 N-terminus −17 83 Amonia loss
 R −43 51 Arg->Leu/Ile substitution
 A, T 26 65 A: ->P substitution; T: unknown
 D, E −1 62 Amidation
 S, T −18 25 Beta elimination
Modifications by ISPTM:
 N 1 1070 Deamidation
 M 16 537 Oxidation
 N-terminus 42 340 Acetylation of protein N-terminal
 N-terminal Q −17 150 Pyro-glu modification of N-terminal Q
 C −17 91 Pyro-CamC
 W 16 57 Oxidation
 Q 1 48 Deamidation
 S, T −18 46 Beta elimination
 D 14 17 Methylation
 P 16 14 Hydroxylation
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